VERTEX PHARMACEUTICALS INC / MA (VRTX)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of
Q1 2024
Type / Class
Equity / COM
Shares, Excl. Options Q1 2024
$226 M
Holdings value Q1 2024
$94.5 B
Value change Q1 2024
-$1.65 B
Grand Portfolio weight change Q1 2024
-0.003%
Number of holders
1526
Number of Buys Q1 2024
736
Number of Sells Q1 2024
-592
Average Buys Q1 2024 %
+0.023%
Average Sells Q1 2024 %
-0.01%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 226 M $94.5 B -$1.65 B $418.01 1,430
2023 Q4 229 M $93 B +$514 M $406.89 1,403
2023 Q3 231 M $80.4 B -$566 M $347.74 1,252
2023 Q2 228 M $80.3 B -$1.53 B $351.91 1,247
2023 Q1 236 M $74.4 B +$552 M $315.07 1,172
2022 Q4 235 M $67.9 B -$18.5 M $288.78 1,183
2022 Q3 234 M $67.8 B +$550 M $289.54 1,090
2022 Q2 227 M $64 B +$527 M $281.79 1,076
2022 Q1 216 M $56.3 B +$112 M $260.97 1,032
2021 Q4 223 M $48.9 B -$339 M $219.60 999
2021 Q3 228 M $41.3 B -$34.4 M $181.39 907
2021 Q2 225 M $45.4 B +$456 M $201.63 953
2021 Q1 235 M $50.4 B -$679 M $214.89 966
2020 Q4 238 M $56.1 B -$995 M $236.34 932
2020 Q3 242 M $65.7 B -$118 M $272.12 914
2020 Q2 242 M $70.2 B -$404 M $290.31 939
2020 Q1 242 M $57.6 B +$326 M $237.95 826
2019 Q4 243 M $53.3 B -$520 M $218.95 788
2019 Q3 245 M $41.6 B +$12.6 M $169.42 689
2019 Q2 241 M $44.2 B +$1.52 B $183.38 697
2019 Q1 244 M $44.9 B +$391 M $183.95 720
2018 Q4 243 M $40.2 B +$323 M $165.71 682
2018 Q3 234 M $45 B +$4.07 M $192.74 681
2018 Q2 241 M $40.9 B +$446 M $169.96 678
2018 Q1 240 M $39.1 B +$125 M $162.98 671
2017 Q4 239 M $35.8 B +$293 M $149.86 629
2017 Q3 237 M $36.1 B +$313 M $152.04 601
2017 Q2 236 M $30.4 B +$9.59 M $128.87 562
2017 Q1 236 M $25.8 B +$2.16 B $109.35 504
2016 Q4 236 M $17.4 B -$343 M $73.67 466
2016 Q3 241 M $21 B +$81.6 M $87.21 476
2016 Q2 240 M $20.6 B +$256 M $86.02 468
2016 Q1 234 M $18.6 B +$171 M $79.49 481
2015 Q4 234 M $29.5 B -$14.6 M $125.83 505
2015 Q3 231 M $24.1 B +$687 M $104.14 480
2015 Q2 227 M $28 B -$368 M $123.48 491
2015 Q1 233 M $27.5 B +$466 M $117.97 470
2014 Q4 229 M $27.3 B -$519 M $118.80 466
2014 Q3 233 M $26.2 B +$764 M $112.31 425
2014 Q2 227 M $21.5 B +$285 M $94.68 409
2014 Q1 223 M $15.8 B +$98.6 M $70.72 390